Long-term expression changes of immune-related genes in prostate cancer after radiotherapy-Reference-Cited by-同舟云学术

Long-term expression changes of immune-related genes in prostate cancer after radiotherapy

Published:2021-08-25 Issue: Volume: Page:
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Eke Iris^ORCID,Aryankalayil Molykutty J.,Bylicky Michelle A.,Sandfort Veit,Vanpouille-Box Claire,Nandagopal Saravanan,Graves Edward E.,Giaccia Amato J.,Coleman C. Norman

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-021-03036-w.pdf

Reference49 articles.

1. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34. https://doi.org/10.3322/caac.21551

2. Vinay DS, Ryan EP, Pawelec G et al (2015) Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Semin Cancer Biol 35:S185–S198. https://doi.org/10.1016/J.SEMCANCER.2015.03.004

3. Aptsiauri N, Cabrera T, Garcia-Lora A, Garrido F (2012) Cancer immune escape: Implications for immunotherapy, Granada, Spain, October 3–5, 2011. In: Cancer Immunology, Immunotherapy. Springer, pp 739–745

4. Lorente D, Fizazi K, Sweeney C, de Bono JS (2016) Optimal treatment sequence for metastatic castration-resistant prostate cancer. Eur Urol Focus 2:488–498

5. Williams SG, Aw Yeang HX, Mitchell C et al (2020) Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report. BMC Urol. https://doi.org/10.1186/s12894-020-00738-8

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune effects of α and β radionuclides in metastatic prostate cancer;Nature Reviews Urology;2024-08-27

2. Multiomic-Based Molecular Landscape of FaDu Xenograft Tumors in Mice after a Combinatorial Treatment with Radiation and an HSP90 Inhibitor Identifies Adaptation-Induced Targets of Resistance and Therapeutic Intervention;Molecular Cancer Therapeutics;2024-02-12

3. Current trends in the promising immune checkpoint inhibition and radiotherapy combination for locally advanced and metastatic urothelial carcinoma;International Journal of Clinical Oncology;2023-10-24

4. Immunogenomic profiles associated with response to life-prolonging agents in prostate cancer;British Journal of Cancer;2023-07-13

5. Emerging evidence for adapting radiotherapy to immunotherapy;Nature Reviews Clinical Oncology;2023-06-06